Agilent Technologies (A) reported its Q1 2025 results, delivering revenue of $1.8 billion with core growth of 4.4% year over year and reported growth of 7.0%, supported by a 2.6% favorable foreign currency headwind. The company maintained its full-year core revenue growth guidance range of...
Agilent Technologies A reported first-quarter fiscal 2025 earnings of $1.36 per share, which fell short of the Zacks Consensus Estimate by 0.52%, though the figure represented a 3.8% year-over-year increase. Revenue for the quarter stood at $1.8 billion, surpassing expectations by 0.27% on a reported...
Agilent Technologies (NYSE:A) received a downgrade from 'buy' to 'hold' by Wall Street Zen, though the stock maintains an average analyst rating of 'Moderate Buy' with a target price of $159.35. While Wall Street Zen initiated coverage recently, other major firms like Piper Sandler and...
Agilent Technologies (NYSE: A) is a mature analytical lab instrument provider spun off from Hewlett-Packard in 1999, operating through Life Sciences, Diagnostics, and CrossLab segments. The company maintains a conservative financial profile with a market cap of $30–$35 billion, paying dividends since FY2012 with modest...
Agilent Technologies, Inc. (NYSE: A) reported Q1 2026 revenue of $1.8 billion, reflecting a 4.4% core year-over-year growth and 7.0% total growth aided by a 2.6% currency tailwind. The company's financial performance was impacted by East Coast snowstorms that disrupted shipping in the final three...
